Document is current

Suárez‐Calvet, Marc

Kleinberger, Gernot

Araque Caballero, Miguel Ángel

Brendel, Matthias

Rominger, Axel

Alcolea, Daniel

Fortea, Juan

Lleó, Alberto

Blesa, Rafael

Gispert, Juan Domingo

Sánchez‐Valle, Raquel

Antonell, Anna

Rami, Lorena

Molinuevo, José L

Brosseron, Frederic

Traschütz, Andreas

Heneka, Michael T

Struyfs, Hanne

Engelborghs, Sebastiaan

Sleegers, Kristel

Van Broeckhoven, Christine

Zetterberg, Henrik

Nellgård, Bengt

Blennow, Kaj

Crispin, Alexander

Ewers, Michael

Haass, Christian

Funding for this research was provided by:

European Commission (PCIG12‐GA‐2012‐334259)

European Research Council (FP7/2007–2013)

European Research Council (321366)

Deutsche Forschungsgemeinschaft (115372)

Cure Alzheimer's Fund

MetLife Foundation Award

Swedish Research Council

Torsten Söderberg Foundation

Royal Swedish Academy of Sciences

Knut and Alice Wallenberg Foundation

Frimurarestiftelsen (115372)

University Research Fund of the University of Antwerp

Institute Born‐Bunge

Foundation for Alzheimer Research

Neurosearch Antwerp

Research Foundation—Flanders

Agency for Innovation by Science and Technology

Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office

Flemish Government Methusalem Excellence Program, Belgium

Flanders Impulse Program on Networks for Dementia Research

EU Joint Program for Neurodegenerative Disease Research (321366)

EU/EFPIA Innovative Medicines Initiative Joint Undertaking (115372)

Belgian Science Policy Office Interuniversity Attraction Poles Program

Flanders Government Initiated Impulse Program on Networks for Dementia Research

Flemish government Initiated Methusalem Excellence Program

University of Antwerp Research Fund, Belgium

Janssen

ADx Neurosciences

Innogenetics/Fujirebio Europe

Lundbeck

Pfizer (115372)

Novartis

UCB

Roche Diagnostics

Nutricia/Danone (115372)

Text and Data Mining valid from 2016-03-03

Version of Record valid from 2016-03-03